A systematic review of the musculoskeletal literature published on NIH/PMC concluded that BPC-157 shows promise for promoting recovery from musculoskeletal injuries across level IV and level V study evidence, covering preclinical data on fractures, tendon ruptures, ligament tears and muscle injuries
By monitoring their health, watching for side effects, and regularly consulting with a healthcare provider, patients can enjoy the long-term benefits of this combination therapy
Monthly costs range from roughly $150 to $400+ depending on the platform and dose
Like what's in that list
reports receiving personal fees for consulting and/or speaking from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Medscape, Merck, Novo Nordisk, Sanofi, and UpToDate
We are here to help you navigate the legal process, both in and out of court, and fight for the compensation you deserve